SCHEMBL30402413

SCHEMBL30402413

Cn1cc(C(=O)Nc2ccc3c(c2)OCCO3)c2ccccc2c1=O

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TAF1 P21675 1/20 0.65
▸ RAB9A P51151 10/20 0.60
▸ NPC1 O15118 8/20 0.60
▸ MAPT P10636 6/20 0.60
▸ TP53 P04637 4/20 0.60
▸ SMN1; SMN2 Q16637 4/20 0.60
▸ TSHR P16473 1/20 0.60
▸ ALDH1A1 P00352 4/20 0.58
▸ MITF O75030 1/20 0.58
▸ THRB P10828 1/20 0.58
▸ NPSR1 Q6W5P4 1/20 0.58
▸ HPGD P15428 2/20 0.58
▸ LMNA P02545 2/20 0.58
▸ KDM4E B2RXH2 1/20 0.58
▸ HSD17B10 Q99714 1/20 0.58
▸ NR2F2 P24468 1/20 0.56
▸ MAPK1 P28482 1/20 0.56
▸ HTT P42858 1/20 0.56
▸ CREBBP Q92793 1/20 0.56
▸ BRD4 O60885 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20942542 1.00 TAF1 (0.65) TAF1RAB9ANPC1MAPTTP53
SCHEMBL20942536 0.96 TAF1 (0.60) TAF1RAB9ANPC1MAPTTP53
SCHEMBL20942538 0.93 NPC1 (0.60) TAF1RAB9ANPC1MAPTTP53
SCHEMBL20942203 0.86 TAF1 (0.49) TAF1RAB9ANPC1MAPTTP53
SCHEMBL20942502 0.82 USP2 (0.67) RAB9ANPC1SMN1; SMN2TSHRALDH1A1
SCHEMBL19276574 0.82 BRD4 (0.52) RAB9ANPC1MAPTSMN1; SMN2ALDH1A1
SCHEMBL20942233 0.81 ALDH1A1 (0.59) TAF1RAB9ANPC1MAPTTP53
SCHEMBL19276576 0.81 NPC1 (0.60) TAF1RAB9ANPC1MAPTTP53
SCHEMBL20942497 0.81 NPC1 (0.58) TAF1RAB9ANPC1MAPTTP53
SCHEMBL20942221 0.79 TAF1 (1.00) TAF1RAB9ANPC1MAPTTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4430192-A2 LNCRNA TRANSCRIPTS IN MELANOMAGENESIS The Regents of the University of California (US) 2024-09-18 — — EP claimed
WO-2023086552-A2 LNCRNA TRANSCRIPTS IN MELANOMAGENESIS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2023-05-19 — — WO claimed
US-20250197864-A1 LNCRNA TRANSCRIPTS IN MELANOMAGENESIS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2025-06-19 — — US disclosed
US-20250011881-A1 MYC-HSF1 DUAL AMPLIFICATION AS A BIOMARKER FOR CANCER TREATMENT THE TRUSTEES OF INDIANA UNIVERSITY (US) 2025-01-09 — — US disclosed
US-20240309458-A1 MYC-HSF1 DUAL AMPLIFICATION AS A BIOMARKER FOR CANCER TREATMENT NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2024-09-19 — — US disclosed
EP-4430192-A2 LNCRNA TRANSCRIPTS IN MELANOMAGENESIS The Regents of the University of California (US) 2024-09-18 — — EP disclosed
WO-2023086552-A2 LNCRNA TRANSCRIPTS IN MELANOMAGENESIS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2023-05-19 — — WO disclosed
Send feedback